Donate blood and tissue to study recurrent or metastatic cancers
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study collects and studies blood and, when possible, small tissue samples from people with prostate or bladder/urothelial cancer that has come back or spread. The goal is to better understand these cancers and support future research that may lead to better care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have prostate cancer or bladder/urothelial cancer that is locally recurrent or has spread to nearby areas or distant sites
- There is a tumor spot in bone or soft tissue that can be safely biopsied, or you have surgery/procedures where extra tissue can be taken with minimal added risk
- Your blood counts are high enough: platelets above 50,000, white blood cells above 1,500, and hemoglobin above 8
- Blood clotting tests are within limits (INR under 1.5, PTT under 45)
- You can understand the study and sign informed consent
- You should not have a history of unexplained excessive bleeding after previous procedures
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a blood test that detects tumor DNA can help guide the use of immunotherapy (nivolumab with or without relatlimab) after surgery for urothelial cancer. The goal is to see if starting immunotherapy based on the blood test results can prevent the cancer from coming back.
This study collects urine and tissue samples from people being checked for blood in their urine (hematuria) to build a 'bladder bank' for future research. By donating samples, you help scientists learn more about bladder conditions and improve diagnosis.
This study collects blood and tissue samples from people with cancer or suspected cancer, or from their blood relatives. Researchers use these samples to better understand cancer and develop new treatments.
This study looks at urothelial cancer (often bladder cancer) samples taken during diagnosis or standard treatment. It may help researchers better understand the disease by using tissue that doctors already need to collect for care.
This study collects clinical and tissue samples from people who are having surgery for bladder cancer and related urinary-tract tumors. It aims to improve understanding of cancer and may help future care by building a large research dataset.
This study collects samples (blood, urine, tissue) and health information from people with bladder or urinary tract cancers. The goal is to learn more about these cancers to improve detection and treatment in the future.
Hear when a new Malignant Solid Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.